Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SHR2554”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Testing effectiveness (Phase 2)Looking for participantsNCT07102901
What this trial is testing

Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma

Who this might be right for
Advanced Gastric CancerMetastatic Gastric CancerGastroesophageal Junction Adenocarcinoma
Jiangsu HengRui Medicine Co., Ltd. 351
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06368167
What this trial is testing

A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Jiangsu HengRui Medicine Co., Ltd. 105
Testing effectiveness (Phase 2)UnknownNCT06173999
What this trial is testing

SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Jiangsu HengRui Medicine Co., Ltd. 100
Early research (Phase 1)Not Yet RecruitingNCT06712173
What this trial is testing

Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Peripheral T Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07562568
What this trial is testing

SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more
The First Affiliated Hospital of Soochow University 160
Early research (Phase 1)Study completedNCT04577885
What this trial is testing

A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult Subjects

Who this might be right for
Healthy
Jiangsu HengRui Medicine Co., Ltd. 18
Early research (Phase 1)UnknownNCT05049083
What this trial is testing

A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects

Who this might be right for
Lymphoma
Jiangsu HengRui Medicine Co., Ltd. 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07347288
What this trial is testing

SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma

Who this might be right for
PTCL
The First Affiliated Hospital with Nanjing Medical University 30
Early research (Phase 1)Study completedNCT04335266
What this trial is testing

A Food Effect Study of SHR2554 on Healthy Chinese Male Adult Subjects

Who this might be right for
Healthy Adult Subjects
Jiangsu HengRui Medicine Co., Ltd. 20
Testing effectiveness (Phase 2)UnknownNCT05896046
What this trial is testing

SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Hodgkin Lymphoma
Chinese PLA General Hospital 100
Early research (Phase 1)Study completedNCT04627129
What this trial is testing

A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult Subjects

Who this might be right for
Healthy Adult Subjects
Jiangsu HengRui Medicine Co., Ltd. 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07725705
What this trial is testing

SHR2554 Plus Liposomal Mitoxantrone as First-line Treatment for Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
PTCLFirst Line Treatment
Institute of Hematology & Blood Diseases Hospital, China 44
Testing effectiveness (Phase 2)Looking for participantsNCT06519526
What this trial is testing

Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Who this might be right for
Relapsed/Refractory Peripheral T Cell Lymphoma
Fudan University 25
Testing effectiveness (Phase 2)Looking for participantsNCT07294664
What this trial is testing

PDL1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer

Who this might be right for
Advanced Gastric CancerSHR1701
The First Affiliated Hospital of Zhengzhou University 78
Testing effectiveness (Phase 2)Ended earlyNCT03741712
What this trial is testing

SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 9
Early research (Phase 1)Study completedNCT06093945
What this trial is testing

Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects

Who this might be right for
Malignant Tumor
Jiangsu HengRui Medicine Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT07311408
What this trial is testing

SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure

Who this might be right for
Gastric Cancer (GC)Gastroesophageal Junction Adenocarcinoma
Jingdong Zhang 40
Testing effectiveness (Phase 2)Looking for participantsNCT07175220
What this trial is testing

Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects

Who this might be right for
Locally Advanced or Metastatic Non-small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07575412
What this trial is testing

SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more
The First Affiliated Hospital of Soochow University 180
Early research (Phase 1)Study completedNCT05592262
What this trial is testing

Pharmacokinetic Test of High-fat Diet After Oral Administration of SHR2554 in Healthy Subjects

Who this might be right for
Malignant Tumor
Jiangsu HengRui Medicine Co., Ltd. 20
Next Page